YARDLEY, Pa., July 02, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the Company has been named one of the Philadelphia Business Journal’s “Best Places to Work” for 2018 in the medium-sized company category.
“We are proud of every single person on the Optinose team for creating a Philadelphia Business Journal ‘Best Place to Work,’ because we know that our company’s wonderful culture is a result of the ownership that is felt by every colleague,” said Peter Miller, CEO of Optinose. “Building a company where people love to come to work has been a priority for us ever since we started Optinose.”
“Recognition as a ‘Best Place to Work’ means our team is succeeding in creating the shared culture we all aspire to, one that is based on core values,” added Ramy Mahmoud, President and Chief Operating Officer of Optinose. “Even with our rapid growth, our colleagues are successfully sustaining core values such as Friendship, Authenticity, Openness, Possibility Thinking, and of course ‘One Mission.’ These shared values are reflected in how we work every day and we believe they have been essential to our track record of success in both developing and commercializing innovative new products.”
Over the past year, Optinose has grown from 22 to more than 90 colleagues globally, with over 60 based in the headquarters in Yardley. It has also achieved a second FDA product approval, launched an important new product (XHANCETM), and completed a successful IPO. More information about the shared purpose that unites the people of Optinose is here, and more information about career opportunities is here.
The Philadelphia Business Journal names companies to its “Best Places to Work” list using a rigorous scientific process based on responses to an independent employee engagement survey conducted by Quantum Workplace. As a finalist, Optinose’s culture was favorably ranked by employees in areas including work environment, people, personal growth, and professional development.
Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S., the U.K. and Norway. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.
Optinose Investor Contact
Optinose Media Contact
Kate Traynor, Sloane & Company